Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease Risk: Impact of Study Design Differences on Comparative Safety Results

12/12/2023
27/03/2024
EU PAS number:
EUPAS108001
Study
Ongoing
Documents
Study protocol
Initial protocol
English (773.64 KB - PDF) View document
Study results
Study report
Other information